CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ASCO 发布 CAR-T 细胞治疗指南：多学科团队的建议有助于识别、检查、评估和管理最常见的嵌合抗原受体 (CAR) T 细胞相关毒性：多学科团队的建议有助于识别、检查、评估和管理最常见的嵌合抗原受体 (CAR) T 细胞相关毒性
英文原题：ASCO releases guideline on CAR T-cell therapy: A multidisciplinary team's recommendations help in the recognition, workup, evaluation, and management of the most common chimeric antigen receptor (CAR) T-cell-related toxicities: A multidisciplinary team's recommendations help in the recognition, workup, evaluation, and management of the most common chimeric antigen receptor (CAR) T-cell-related toxicities.
查看英文原题
ASCO releases guideline on CAR T-cell therapy: A multidisciplinary team's recommendations help in the recognition, workup, evaluation, and management of the most common chimeric antigen receptor (CAR) T-cell-related toxicities: A multidisciplinary team's recommendations help in the recognition, workup, evaluation, and management of the most common chimeric antigen receptor (CAR) T-cell-related toxicities.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
摘要
这条来源本身就没有摘要（PubMed 未提供），不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。
论文信息
- 作者
- O'Rourke K
- 文献类型
- 新闻
- 期刊
- Cancer2022 Feb 1
- 原文标识
- PubMed 35050523 · DOI 10.1002/cncr.34080